Baricitinib vs. placebo or adalimumab in patients with active rheumatoid arthritis and an inadequate response to background methotrexate therapy: results of a phase 3 study
Author(s):
Taylor, P.; Keystone, E.C.; Heijde, D. van der; Tanaka, Y.; Ishii, T.; Emoto, K.; Yang, L.; Arora, V.; Gaich, C.; Rooney, T.; Schlichting, D.; Macias, W.L.; Bono, S. de; Weinblatt, M.E.; Larsson, E.
Published
2016
Publication type
Article / Letter to editor
Date issued
2016-12-31
Language
English
Is part of
Scandinavian Journal of Rheumatology (2016), Vol. 45, p. 8-8
